Literature DB >> 22634528

Merkel cell carcinoma: what do we know about it and what should we do?

Isabel Prieto Muñoz1, José Pardo Masferrer, Jesús Olivera Vegas, José Ramón Fortes Alen, Ana M Pérez Casas.   

Abstract

Merkel cell carcinoma (MCC) is a rare primary cutaneous carcinoma of the skin that is highly aggressive, and has a high risk of locoregional and distant spread, a mortality rate considerably higher than that of cutaneous melanoma and poor survival. Its incidence has increased during the past twenty years. The studies published since 2008 have introduced changes in the understanding of its epidemiology and pathogenesis, and consequently the therapeutic approach. Despite this, there is still controversy surrounding its optimal management, which requires clarification. This is the purpose of this review.

Entities:  

Mesh:

Year:  2012        PMID: 22634528     DOI: 10.1007/s12094-012-0817-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  64 in total

1.  Somatostatin analogue scintigraphy in Merkel cell tumours.

Authors:  B K Durani; A Klein; M Henze; U Haberkorn; W Hartschuh
Journal:  Br J Dermatol       Date:  2003-06       Impact factor: 9.302

2.  Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy.

Authors:  Shane E Cotter; Phillip M Devlin; Debjani Sahni; Jorgen L Hansen; Desmond A O'Farrell; Andrea K Ng; Linda C Wang
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

3.  CD56 staining in Merkel cell carcinoma and natural killer-cell lymphoma: magic bullet, diagnostic pitfall, or both?

Authors:  Jennifer M McNiff; Shawn E Cowper; Rossitza Lazova; Antonio Subtil; Earl J Glusac
Journal:  J Cutan Pathol       Date:  2005-09       Impact factor: 1.587

4.  Incidence of Merkel cell carcinoma in renal transplant recipients.

Authors:  Virve Koljonen; Heli Kukko; Erkki Tukiainen; Tom Böhling; Risto Sankila; Eero Pukkala; Harri Sihto; Heikki Joensuu; Lauri Kyllönen; Heikki Mäkisalo
Journal:  Nephrol Dial Transplant       Date:  2009-07-08       Impact factor: 5.992

5.  Short German guidelines: Merkel cell carcinoma.

Authors:  Jürgen Becker; Cornelia Mauch; Rolf-Dieter Kortmann; Ulrich Keilholz; Friedrich Bootz; Claus Garbe; Axel Hauschild; Ingrid Moll
Journal:  J Dtsch Dermatol Ges       Date:  2008-05       Impact factor: 5.584

6.  Patients with clinically node negative extremity Merkel cell carcinoma: The importance of identifying and treating patients with microscopic nodal metastases.

Authors:  Michael Veness; Julie Howle
Journal:  Australas J Dermatol       Date:  2010-10-13       Impact factor: 2.875

7.  Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.

Authors:  Michelle Heath; Natalia Jaimes; Bianca Lemos; Arash Mostaghimi; Linda C Wang; Pablo F Peñas; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2008-03       Impact factor: 11.527

8.  Radiotherapy alone for primary Merkel cell carcinoma.

Authors:  Laurent Mortier; Xavier Mirabel; Charles Fournier; Frederic Piette; Eric Lartigau
Journal:  Arch Dermatol       Date:  2003-12

9.  Prognostic value of tumor thickness in patients with Merkel cell carcinoma.

Authors:  Stephanie R Goldberg; James P Neifeld; William J Frable
Journal:  J Surg Oncol       Date:  2007-06-15       Impact factor: 3.454

10.  Toward better management of merkel cell carcinoma using a consensus staging system, new diagnostic codes and a recently discovered virus.

Authors:  J G Iyer; S Koba; P Nghiem
Journal:  Actas Dermosifiliogr       Date:  2009-12
View more
  2 in total

1.  A rapidly growing lid lump.

Authors:  Su-Yin Koay; Richard M H Lee; Charles Hugkulstone; Ian Aureliano Stephen Rodrigues
Journal:  BMJ Case Rep       Date:  2014-08-14

2.  Effect of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against human Merkel cell carcinoma MKL-1 cells.

Authors:  Zhenyu Lin; Hong Mei; Jiquan Fan; Zhongyuan Yin; Gang Wu
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.